This protocol is judged by an institutional overview board, an unbiased group that opinions any scientific trials involving humans. If a study will involve a Routine I drug, once the board approves the protocol as ethical, the scientists really have to apply for an investigational new drug (IND) quantity from the FDA.Weiser urged social networking